Patents Assigned to SHANDONG XINHUA PHARMACEUTICAL CO., LTD.
  • Patent number: 10399931
    Abstract: An octahydroanthracene compound having the structure shown in formula (I) and (II), preparation method and application thereof are disclosed. The octahydroanthracene compound has a good therapeutic effect on tumors and neurodegenerative diseases. The preparation of the octahydroanthracene compound is mainly carried out by using benzene as a starting material, and being subjected to Friedel-Crafts reaction, nitration, reduction, (sulfo-) amide formation, reduction, urea formation or amide formation, thus obtaining a target compound.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: September 3, 2019
    Assignees: SHANDONG XINHUA PHARMACEUTICAL CO., LTD., SHENYANG PHARMACEUTICAL UNIVERSITY
    Inventors: Guoliang Chen, Zhonghui Zheng, Libo Zou, Daiming Zhang, Chunling Yuan, Fulong Ren, Xuefei Bao, Jinheng Gao, Linbo Zhou, Wuhong Fang
  • Publication number: 20190071393
    Abstract: An octahydroanthracene compound having the structure shown in formula (I) and (II), preparation method and application thereof are disclosed. The octahydroanthracene compound has a good therapeutic effect on tumors and neurodegenerative diseases. The preparation of the octahydroanthracene compound is mainly carried out by using benzene as a starting material, and being subjected to Friedel-Crafts reaction, nitration, reduction, (sulfo-) amide formation, reduction, urea formation or amide formation, thus obtaining a target compound.
    Type: Application
    Filed: March 23, 2017
    Publication date: March 7, 2019
    Applicants: SHENYANG PHARMACEUTICAL UNIVERSITY, SHANDONG XINHUA PHARMACEUTICAL CO., LTD.
    Inventors: Guoliang CHEN, Zhonghui ZHENG, Libo ZOU, Daiming ZHANG, Chunling YUAN, Fulong REN, Xuefei BAO, Jinheng GAO, Linbo ZHOU, Wuhong FANG